EDGAR Filing Documents for 0001214659-23-016460

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

SEC Accession No. 0001214659-23-016460

Filing Date

2023-12-14

Accepted

2023-12-14 17:20:43

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 3	z127230f1a3.htm	F-1/A	1328070
2	EXHIBIT 1.1	ex1_1.htm	EX-1.1	253452
3	EXHIBIT 4.17	ex4_17.htm	EX-4.17	120857
4	EXHIBIT 4.18	ex4_18.htm	EX-4.18	113019
5	EXHIBIT 4.19	ex4_19.htm	EX-4.19	120876
6	EXHIBIT 4.20	ex4_20.htm	EX-4.20	121798
7	EXHIBIT 5.1	ex5_1.htm	EX-5.1	79259
8	EXHIBIT 5.2	ex5_2.htm	EX-5.2	16943
9	EXHIBIT 10.26	ex10_26.htm	EX-10.26	21339
10	EXHIBIT 23.1	ex23_1.htm	EX-23.1	6546
11	EXHIBIT 107	ex107.htm	EX-FILING FEES	38757
12	GRAPHIC	biodexa_logo.jpg	GRAPHIC	13595
13	GRAPHIC	mazars_logomed.jpg	GRAPHIC	10264
14	GRAPHIC	pipeline1.jpg	GRAPHIC	34967
15	GRAPHIC	pipeline2.jpg	GRAPHIC	18978
	Complete submission text file	0001214659-23-016460.txt		2329718

Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ

Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300

Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)